Global OAB Treatment Market Growth (Status and Outlook) 2024-2030

Overactive bladder (OAB) is a common disease characterized by urinary urgency, often accompanied by frequent urination and nocturia, with or without urge urinary incontinence. This report focuses on the OAB treatment drug market, which is divided into: anticholinergic drugs, Mirabegron, Botox and others by drug type.

The global OAB Treatment market size is projected to grow from US$ 4969 million in 2024 to US$ 5441 million in 2030; it is expected to grow at a CAGR of 1.5% from 2024 to 2030.

LPI (LP Information)' newest research report, the “OAB Treatment Industry Forecast” looks at past sales and reviews total world OAB Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected OAB Treatment sales for 2023 through 2029. With OAB Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world OAB Treatment industry.

This Insight Report provides a comprehensive analysis of the global OAB Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on OAB Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global OAB Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for OAB Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global OAB Treatment.

Overactive bladder (OAB) is a common disease, and the incidence of OAB shows an upward trend with age. With the continuous increase in the global elderly population, the number of elderly OAB patients has shown an upward trend year by year, which has attracted further attention from governments and the pharmaceutical treatment market. The OAB treatment drug market has great potential. The introduction of pharmaceutical industry policies, the policy changes and market environment, and the policy trends and future market development trends, although there are challenges, are actually evolving in a direction that is beneficial to innovative enterprises, which is conducive to promoting the long-term standardized development of the industry and providing good opportunities for OAB new drug companies with high-level R&D, production and quality management systems. It will be conducive to promoting the development of the OAB treatment drug industry. With the continuous advancement of technology and the innovation of new instruments, the surge in the number of new drugs discovered, the increase in government funds and the undeveloped emerging markets will further generate profitable markets, thereby promoting the market growth of OAB drugs. With the continuous increase in global healthcare infrastructure spending, the increase in per capita disposable income and the expansion of medical insurance coverage, residents' ability to pay for medical care has increased, driving the development of the OAB drug industry.

This report presents a comprehensive overview, market shares, and growth opportunities of OAB Treatment market by product type, application, key players and key regions and countries.

Segmentation by Type:
    Anticholinergics
    Mirabegron
    Botox
    Others

Segmentation by Application:
    Idiopathic Overactive Bladder
    Neurogenic Overactive Bladder

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

Segmentation by Type:
    Anticholinergics
    Mirabegron
    Botox
    Others

Segmentation by Application:
    Idiopathic Overactive Bladder
    Neurogenic Overactive Bladder

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
    AbbVie
    Astellas Pharma
    Pfizer
    Teva
    Johnson & Johnson
    Kyorin Pharmaceutical

List of Tables
 Table 1. OAB Treatment Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
 Table 2. OAB Treatment Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
 Table 3. Major Players of Anticholinergics
 Table 4. Major Players of Mirabegron
 Table 5. Major Players of Botox
 Table 6. Major Players of Others
 Table 7. OAB Treatment Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
 Table 8. Global OAB Treatment Market Size by Type (2019-2024) & ($ millions)
 Table 9. Global OAB Treatment Market Size Market Share by Type (2019-2024)
 Table 10. OAB Treatment Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
 Table 11. Global OAB Treatment Market Size by Application (2019-2024) & ($ millions)
 Table 12. Global OAB Treatment Market Size Market Share by Application (2019-2024)
 Table 13. Global OAB Treatment Revenue by Player (2019-2024) & ($ millions)
 Table 14. Global OAB Treatment Revenue Market Share by Player (2019-2024)
 Table 15. OAB Treatment Key Players Head office and Products Offered
 Table 16. OAB Treatment Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
 Table 17. New Products and Potential Entrants
 Table 18. Mergers & Acquisitions, Expansion
 Table 19. Global OAB Treatment Market Size by Region (2019-2024) & ($ millions)
 Table 20. Global OAB Treatment Market Size Market Share by Region (2019-2024)
 Table 21. Global OAB Treatment Revenue by Country/Region (2019-2024) & ($ millions)
 Table 22. Global OAB Treatment Revenue Market Share by Country/Region (2019-2024)
 Table 23. Americas OAB Treatment Market Size by Country (2019-2024) & ($ millions)
 Table 24. Americas OAB Treatment Market Size Market Share by Country (2019-2024)
 Table 25. Americas OAB Treatment Market Size by Type (2019-2024) & ($ millions)
 Table 26. Americas OAB Treatment Market Size Market Share by Type (2019-2024)
 Table 27. Americas OAB Treatment Market Size by Application (2019-2024) & ($ millions)
 Table 28. Americas OAB Treatment Market Size Market Share by Application (2019-2024)
 Table 29. APAC OAB Treatment Market Size by Region (2019-2024) & ($ millions)
 Table 30. APAC OAB Treatment Market Size Market Share by Region (2019-2024)
 Table 31. APAC OAB Treatment Market Size by Type (2019-2024) & ($ millions)
 Table 32. APAC OAB Treatment Market Size by Application (2019-2024) & ($ millions)
 Table 33. Europe OAB Treatment Market Size by Country (2019-2024) & ($ millions)
 Table 34. Europe OAB Treatment Market Size Market Share by Country (2019-2024)
 Table 35. Europe OAB Treatment Market Size by Type (2019-2024) & ($ millions)
 Table 36. Europe OAB Treatment Market Size by Application (2019-2024) & ($ millions)
 Table 37. Middle East & Africa OAB Treatment Market Size by Region (2019-2024) & ($ millions)
 Table 38. Middle East & Africa OAB Treatment Market Size by Type (2019-2024) & ($ millions)
 Table 39. Middle East & Africa OAB Treatment Market Size by Application (2019-2024) & ($ millions)
 Table 40. Key Market Drivers & Growth Opportunities of OAB Treatment
 Table 41. Key Market Challenges & Risks of OAB Treatment
 Table 42. Key Industry Trends of OAB Treatment
 Table 43. Global OAB Treatment Market Size Forecast by Region (2025-2030) & ($ millions)
 Table 44. Global OAB Treatment Market Size Market Share Forecast by Region (2025-2030)
 Table 45. Global OAB Treatment Market Size Forecast by Type (2025-2030) & ($ millions)
 Table 46. Global OAB Treatment Market Size Forecast by Application (2025-2030) & ($ millions)
 Table 47. AbbVie Details, Company Type, OAB Treatment Area Served and Its Competitors
 Table 48. AbbVie OAB Treatment Product Offered
 Table 49. AbbVie OAB Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
 Table 50. AbbVie Main Business
 Table 51. AbbVie Latest Developments
 Table 52. Astellas Pharma Details, Company Type, OAB Treatment Area Served and Its Competitors
 Table 53. Astellas Pharma OAB Treatment Product Offered
 Table 54. Astellas Pharma OAB Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
 Table 55. Astellas Pharma Main Business
 Table 56. Astellas Pharma Latest Developments
 Table 57. Pfizer Details, Company Type, OAB Treatment Area Served and Its Competitors
 Table 58. Pfizer OAB Treatment Product Offered
 Table 59. Pfizer OAB Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
 Table 60. Pfizer Main Business
 Table 61. Pfizer Latest Developments
 Table 62. Teva Details, Company Type, OAB Treatment Area Served and Its Competitors
 Table 63. Teva OAB Treatment Product Offered
 Table 64. Teva OAB Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
 Table 65. Teva Main Business
 Table 66. Teva Latest Developments
 Table 67. Johnson & Johnson Details, Company Type, OAB Treatment Area Served and Its Competitors
 Table 68. Johnson & Johnson OAB Treatment Product Offered
 Table 69. Johnson & Johnson OAB Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
 Table 70. Johnson & Johnson Main Business
 Table 71. Johnson & Johnson Latest Developments
 Table 72. Kyorin Pharmaceutical Details, Company Type, OAB Treatment Area Served and Its Competitors
 Table 73. Kyorin Pharmaceutical OAB Treatment Product Offered
 Table 74. Kyorin Pharmaceutical OAB Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
 Table 75. Kyorin Pharmaceutical Main Business
 Table 76. Kyorin Pharmaceutical Latest Developments


List of Figures
 Figure 1. OAB Treatment Report Years Considered
 Figure 2. Research Objectives
 Figure 3. Research Methodology
 Figure 4. Research Process and Data Source
 Figure 5. Global OAB Treatment Market Size Growth Rate 2019-2030 ($ millions)
 Figure 6. OAB Treatment Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
 Figure 7. OAB Treatment Sales Market Share by Country/Region (2023)
 Figure 8. OAB Treatment Sales Market Share by Country/Region (2019, 2023 & 2030)
 Figure 9. Global OAB Treatment Market Size Market Share by Type in 2023
 Figure 10. OAB Treatment in Idiopathic Overactive Bladder
 Figure 11. Global OAB Treatment Market: Idiopathic Overactive Bladder (2019-2024) & ($ millions)
 Figure 12. OAB Treatment in Neurogenic Overactive Bladder
 Figure 13. Global OAB Treatment Market: Neurogenic Overactive Bladder (2019-2024) & ($ millions)
 Figure 14. Global OAB Treatment Market Size Market Share by Application in 2023
 Figure 15. Global OAB Treatment Revenue Market Share by Player in 2023
 Figure 16. Global OAB Treatment Market Size Market Share by Region (2019-2024)
 Figure 17. Americas OAB Treatment Market Size 2019-2024 ($ millions)
 Figure 18. APAC OAB Treatment Market Size 2019-2024 ($ millions)
 Figure 19. Europe OAB Treatment Market Size 2019-2024 ($ millions)
 Figure 20. Middle East & Africa OAB Treatment Market Size 2019-2024 ($ millions)
 Figure 21. Americas OAB Treatment Value Market Share by Country in 2023
 Figure 22. United States OAB Treatment Market Size Growth 2019-2024 ($ millions)
 Figure 23. Canada OAB Treatment Market Size Growth 2019-2024 ($ millions)
 Figure 24. Mexico OAB Treatment Market Size Growth 2019-2024 ($ millions)
 Figure 25. Brazil OAB Treatment Market Size Growth 2019-2024 ($ millions)
 Figure 26. APAC OAB Treatment Market Size Market Share by Region in 2023
 Figure 27. APAC OAB Treatment Market Size Market Share by Type (2019-2024)
 Figure 28. APAC OAB Treatment Market Size Market Share by Application (2019-2024)
 Figure 29. China OAB Treatment Market Size Growth 2019-2024 ($ millions)
 Figure 30. Japan OAB Treatment Market Size Growth 2019-2024 ($ millions)
 Figure 31. South Korea OAB Treatment Market Size Growth 2019-2024 ($ millions)
 Figure 32. Southeast Asia OAB Treatment Market Size Growth 2019-2024 ($ millions)
 Figure 33. India OAB Treatment Market Size Growth 2019-2024 ($ millions)
 Figure 34. Australia OAB Treatment Market Size Growth 2019-2024 ($ millions)
 Figure 35. Europe OAB Treatment Market Size Market Share by Country in 2023
 Figure 36. Europe OAB Treatment Market Size Market Share by Type (2019-2024)
 Figure 37. Europe OAB Treatment Market Size Market Share by Application (2019-2024)
 Figure 38. Germany OAB Treatment Market Size Growth 2019-2024 ($ millions)
 Figure 39. France OAB Treatment Market Size Growth 2019-2024 ($ millions)
 Figure 40. UK OAB Treatment Market Size Growth 2019-2024 ($ millions)
 Figure 41. Italy OAB Treatment Market Size Growth 2019-2024 ($ millions)
 Figure 42. Russia OAB Treatment Market Size Growth 2019-2024 ($ millions)
 Figure 43. Middle East & Africa OAB Treatment Market Size Market Share by Region (2019-2024)
 Figure 44. Middle East & Africa OAB Treatment Market Size Market Share by Type (2019-2024)
 Figure 45. Middle East & Africa OAB Treatment Market Size Market Share by Application (2019-2024)
 Figure 46. Egypt OAB Treatment Market Size Growth 2019-2024 ($ millions)
 Figure 47. South Africa OAB Treatment Market Size Growth 2019-2024 ($ millions)
 Figure 48. Israel OAB Treatment Market Size Growth 2019-2024 ($ millions)
 Figure 49. Turkey OAB Treatment Market Size Growth 2019-2024 ($ millions)
 Figure 50. GCC Countries OAB Treatment Market Size Growth 2019-2024 ($ millions)
 Figure 51. Americas OAB Treatment Market Size 2025-2030 ($ millions)
 Figure 52. APAC OAB Treatment Market Size 2025-2030 ($ millions)
 Figure 53. Europe OAB Treatment Market Size 2025-2030 ($ millions)
 Figure 54. Middle East & Africa OAB Treatment Market Size 2025-2030 ($ millions)
 Figure 55. United States OAB Treatment Market Size 2025-2030 ($ millions)
 Figure 56. Canada OAB Treatment Market Size 2025-2030 ($ millions)
 Figure 57. Mexico OAB Treatment Market Size 2025-2030 ($ millions)
 Figure 58. Brazil OAB Treatment Market Size 2025-2030 ($ millions)
 Figure 59. China OAB Treatment Market Size 2025-2030 ($ millions)
 Figure 60. Japan OAB Treatment Market Size 2025-2030 ($ millions)
 Figure 61. Korea OAB Treatment Market Size 2025-2030 ($ millions)
 Figure 62. Southeast Asia OAB Treatment Market Size 2025-2030 ($ millions)
 Figure 63. India OAB Treatment Market Size 2025-2030 ($ millions)
 Figure 64. Australia OAB Treatment Market Size 2025-2030 ($ millions)
 Figure 65. Germany OAB Treatment Market Size 2025-2030 ($ millions)
 Figure 66. France OAB Treatment Market Size 2025-2030 ($ millions)
 Figure 67. UK OAB Treatment Market Size 2025-2030 ($ millions)
 Figure 68. Italy OAB Treatment Market Size 2025-2030 ($ millions)
 Figure 69. Russia OAB Treatment Market Size 2025-2030 ($ millions)
 Figure 70. Egypt OAB Treatment Market Size 2025-2030 ($ millions)
 Figure 71. South Africa OAB Treatment Market Size 2025-2030 ($ millions)
 Figure 72. Israel OAB Treatment Market Size 2025-2030 ($ millions)
 Figure 73. Turkey OAB Treatment Market Size 2025-2030 ($ millions)
 Figure 74. GCC Countries OAB Treatment Market Size 2025-2030 ($ millions)
 Figure 75. Global OAB Treatment Market Size Market Share Forecast by Type (2025-2030)
 Figure 76. Global OAB Treatment Market Size Market Share Forecast by Application (2025-2030)

AbbVie
Astellas Pharma
Pfizer
Teva
Johnson & Johnson
Kyorin Pharmaceutical

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

• Primary Source
  Players/Suppliers
  Industry Experts
  Distributors/Traders
  Opinion Leaders
  Front-line Staff
  Marketing Executives

  Secondary Source
  Journals and Periodicals
  Government Bodies
  Annual Reports
  Presentations
  Paid Databases
  LPI Internal Repository

• Data Synthesis
  Information Gathering
  Collation of Data
  Estimation of Key Figures
  Analysis of Derived Insights

  Data Validation
  Triangulation with Data Models
  Reference Against Proprietary
  Databases
  Corroboration with Industry Experts

• Qualitative Analysis
  Market drivers
  Market challenges
  Market trends
  Five forces analysis

  Qualitative Analysis
  Market size and forecast
  Market segmentation
  Geographical insights
  Competitive landscape